controlled release formulation comprising octreotide and two or more polylactide-co-glycolide polymers, use, microparticle manufacturing process and kit

摘要

CONTROLLED RELEASE FORMULATION UNDERSTANDING OCTREOTIDE AND TWO OR MORE POLYMACTIDE-CO-Glycolide POLYMERS, USE, MICROPARTY AND KIT MANUFACTURING PROCESSES. The present invention relates to controlled release formulations comprising as an active ingredient octreotide or a pharmaceutically acceptable salt thereof and two or more different polylactide co-glycolide polymers (PLGAs).